학술논문
Ritonavir-Boosted Exposure of Kinase Inhibitors: an Open Label, Cross-over Pharmacokinetic Proof-of-Concept Trial with Erlotinib
Document Type
Article
Author
Source
In: Pharmaceutical Research . (Pharmaceutical Research, April 2022, 39(4):669-676)
Subject
Language
English
ISSN
1573904X
07248741
07248741